Inspire Investing’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,351
Closed -$1.07M 768
2022
Q3
$1.07M Buy
4,351
+164
+4% +$44.3K 0.15% 123
2022
Q2
$1.04M Sell
4,187
-56
-1% -$15.1K 0.14% 130
2022
Q1
$1.41M Buy
4,243
+452
+12% +$139K 0.16% 129
2021
Q4
$1.36M Buy
3,791
+356
+10% +$120K 0.16% 137
2021
Q3
$1.12M Buy
3,435
+1,501
+78% +$508K 0.14% 169
2021
Q2
$604K Buy
1,934
+683
+55% +$210K 0.08% 258
2021
Q1
$399K Buy
+1,251
New +$400K 0.06% 408

Other funds holding ABMD

Inspire Investing's ABMD Position: Q4 2022 in Review

Inspire Investing sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,351 shares — an estimated $1.07M sold.

Inspire Investing first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $1.41M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Inspire Investing reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Inspire Investing sold 4,351 Abiomed Inc shares in Q4 2022, an estimated $1.07M.
  • Inspire Investing first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • Inspire Investing's Abiomed Inc position peaked at $1.41M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Inspire Investing's 13F filing for Q4 2022, filed 26 Jan 2023.